-
公开(公告)号：US20190342486A1
公开(公告)日：2019-11-07
申请号：US16474620
申请日：2018-01-30
申请人： KOWA COMPANY, LTD.
发明人： Tomohisa AZEGAMI
IPC分类号： H04N5/232
摘要： [Problem] To enable imaging to be performed with appropriate timing.[Solution] In a camera manipulation device 1 according to the present invention, a trigger signal T12 is issued and imaging is begun when a prescribed command is transmitted from a control circuit side to an imaging unit side (see S12). Because the issuance of such trigger signal T12 is not accepted before a character reception start command is issued, it is possible to perform imaging with appropriate timing.
-
公开(公告)号：US20190328509A1
公开(公告)日：2019-10-31
申请号：US16467473
申请日：2016-12-07
申请人： Kowa Company, Ltd.
发明人： Haruo ISHIKAWA
摘要： To realize a toric ophthalmic lens including an edge that makes it possible to design a lens contributing to secondary cataract prevention without deteriorating a degree of freedom of lens design. The toric ophthalmic lens is a toric ophthalmic lens in which, in a top view of an optical portion, a substantially flat portion having a substantially fixed edge thickness of the optical portion is provided to overlap a steep meridian of a toric surface of the optical portion.
-
公开(公告)号：US10413170B2
公开(公告)日：2019-09-17
申请号：US15107504
申请日：2014-12-22
申请人： KOWA COMPANY, LTD.
发明人： Satoshi Shimada , Takuya Hara
摘要： Through the present invention, a perimetry result is obtained for a position on a retina surface designated as a position to be tested. As illustrated in the drawing, “the position of a ganglion cell (RGC)” and “the position of a photoreceptor cell (C) for sending information to the ganglion cell (RGC)” are offset on the retina surface (macular part). Here, when position (P1) is designated as a test position for testing the functioning of a ganglion cell at position (P1), the perimeter of the present invention finds “the position (P2) of the photoreceptor cell for sending information to the ganglion cell at position (P1),” presents a visual target at position (P2) rather than position (P1), and tests a visual field. The information of the visual target is sent to the ganglion cell at position (P1), and the functioning of the ganglion cell can therefore be tested. The test result is correlated with the position (P1) and displayed, and the ganglion cell at the designated position (P1) can be therefore be tested.
-
公开(公告)号：US20190258075A1
公开(公告)日：2019-08-22
申请号：US16374849
申请日：2019-04-04
申请人： KOWA COMPANY, LTD.
发明人： Hirofumi YAGI
摘要： A lens barrel detachably attached to a camera body includes a fixed tube section that has a base end installed at the camera body, and a top end, a first pitch screw section being formed on an inner peripheral surface of the top end; a movable tube section that is a tube member configured to hold a plurality of lens and has a second pitch screw section on the movable tube side formed at an outer peripheral surface, and is located so as to be movable inside the fixed tube section in such a state that the second pitch screw section is threadedly engaged with the first pitch screw section, the plurality of lens including two group of lenses, a first group and a second group, held within the movable tube section. The movable tube section having a fixed diaphragm plate that is detachable.
-
公开(公告)号：US10376523B2
公开(公告)日：2019-08-13
申请号：US15514259
申请日：2015-09-25
申请人： KOWA COMPANY, LTD.
发明人： Shin Sugimoto
IPC分类号： A61K31/551 , A61K47/18 , A61K9/08 , A61P27/02 , A61K9/00 , A61K31/435 , A61K33/42
摘要： An aqueous composition having an excellent antiseptic effect is provided. An aqueous composition containing: a compound represented by Formula (1), a salt thereof, or a solvate of the compound or the salt thereof, where X represents a halogen atom, and a quaternary ammonium surfactant. A method for producing an aqueous composition with an antiseptic effect, by incorporating a compound represented by Formula (1), a salt thereof, or a solvate of the compound or the salt thereof and a quaternary ammonium surfactant into the aqueous composition.
-
公开(公告)号：US20190104698A1
公开(公告)日：2019-04-11
申请号：US16092034
申请日：2017-04-19
申请人： KOWA COMPANY, LTD.
发明人： Naoki MIWA , Daisuke NITTA
IPC分类号： A01G31/02
摘要： [Problem] Provided is a compact cultivation device which has a number of management items (parameters) such as air temperature and CO2 concentration in cultivation space.[Solution] A compact cultivation device 1 according to the present invention is provided with; an air conditioning sensor 6 which detects the air temperature, the CO2 concentration, the humidity, or an air current in a cultivation space A; and a nutrient liquid sensor 8 which detects the temperature, the flow rate, the EC, or the pH of a cultivation liquid B. The compact cultivation device 1 is configured to allow cultivation of a plant V while controlling various management items detected by the sensors 6, 8.
-
公开(公告)号：US20190030005A1
公开(公告)日：2019-01-31
申请号：US16150514
申请日：2018-10-03
申请人： KOWA COMPANY, LTD.
发明人： Toshiaki Takizawa
IPC分类号： A61K31/423 , A61K31/202 , A61K31/232
摘要： This invention provides a combination-drug composition and a combination use of pharmaceuticals for preventing and/or treating dyslipidemia states, such as hyper-LDL cholesterolemia, in mammals, including humans. This invention pertains to a drug composition for preventing and/or treating dyslipidemia and the like, said drug composition comprising the following: (R)-2-[3-[[N-(benzoxazole-2-yl)-N-3-(4-methoxyphenoxy)propyl] aminomethyl]phenoxy] butyric acid, a salt thereof, or a solvate of either; and an omega-3 fatty acid or an ester derivative of an ω-3 fatty acid.
-
公开(公告)号：US20180256595A1
公开(公告)日：2018-09-13
申请号：US15755700
申请日：2016-08-31
申请人： KOWA COMPANY, LTD.
发明人： Kenji Kawamata , Kazushi Maruo , Hideki Suganami
IPC分类号： A61K31/551 , A61P27/06
CPC分类号： A61K31/551 , A61K45/00 , A61P27/06
摘要： The present invention pertains to a drug available for long-term continuous administration for preventing or treating glaucoma or ocular hypertension, said drug showing no decrease in efficacy during long-term administration and exhibiting a stable ocular hypotensive effect. The present invention pertains to a therapeutic agent for glaucoma or ocular hypertension that is to be continuously administered for a long period of time, said drug comprising an Rho kinase inhibitor, more specifically, to a therapeutic agent comprising an Rho kinase inhibitor for treating glaucoma or ocular hypertension in a patient suffering from glaucoma or ocular hypertension who has been administered with a therapeutic agent comprising the Rho kinase inhibitor for treating glaucoma or ocular hypertension continuously over a definite period of time and needs a further enhanced ocular hypotensive effect.
-
公开(公告)号：US20180250274A1
公开(公告)日：2018-09-06
申请号：US15903279
申请日：2018-02-23
申请人： KOWA COMPANY, LTD.
IPC分类号： A61K31/423 , A61K31/575 , A61P1/16
CPC分类号： A61K31/423 , A61K31/575 , A61P1/16
摘要： The present invention relates to a pharmaceutical composition for the treatment of primary biliary cirrhosis (PBC), in which containing a therapeutically effective amount of (R)-2-[3-[[N-(benzoxazol-2-yl)-N-3-(4-methoxyphenoxy)propyl]aminomethyl]phenoxy] butyric acid, a salt thereof, or a solvate thereof.
-
公开(公告)号：US20180224712A1
公开(公告)日：2018-08-09
申请号：US15504419
申请日：2015-09-07
申请人： KOWA COMPANY, LTD.
发明人： Shuichi TOMINAGA , Suguru HANZAWA
摘要： In the present invention, an edge face of an diaphragm ring (4) has a part (a locked portion) wherein a plurality of depressions (62) are formed and a substantially flat surface wherein no depression (62) is formed, and by a simple operation of operating a link releaser (52) so as to rotate the diaphragm ring (4), it is possible to switch between a click mode and a non-click mode. When taking still images, a diaphragm value can be fixed by using the click mode, and when video is taken, the diaphragm value can be smoothly changed during imaging by using the non-click mode.
-
-
-
-
-
-
-
-
-
搜索结果
256 条记录 (耗时 0.031 秒)